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In his writings on the milieu intérieur, 
Claude Bernard first hypothesized on the 
presence of feedback mechanisms within 
the cell to maintain its steady-state physiol-
ogy.1 Walter Bradford Cannon would sub-
sequently build on this concept and coin 
the term homeostasis. To date, numerous 
counter-regulatory mechanisms have been 
characterized in the cell, illustrating the 
dynamic nature of the intracellular envi-
ronment. Among the more recently discov-
ered is the microRNA (miRNA) pathway, 
and as of this writing, 2578 mature human 
miRNAs have been annotated in the miR-
Base database V20, which now catalogs 
206 different plant and animal species.2 
Importantly, since their identification in 
C. elegans, a canonical pathway has now 
been identified to describe how miR-
NAs are processed and incorporated 
into Argonaute-containing complexes to 
maintain their effect on gene expression 
(Fig. 1). Many insights into the functional 
role of miRNAs have been recently made, 
improving our understanding of how these 
small RNAs integrate into the already 
complex landscape of regulating gene 
expression. Most notably, based on a num-
ber of miRNA-knockout mouse models 
showing subtle phenotypes under steady-
state conditions, a hypothesis has gradually 
emerged suggesting the miRNA pathway 
contributes to cellular stress responses.3 
Moreover, these observations are further 
supported by our recent study focusing on 
the role of Argonaute2 (Ago2) in the com-
pensatory proliferation of the pancreatic β 
cell during insulin resistance.4 These recent 
findings culminate over 10 y since our ini-
tial study, which identified miR-375, a 
miRNA now established among the high-
est expressed sequences in this cell type.5
The very first loss- and gain-of-func-
tion studies revealed this miRNA as a 
negative regulator of insulin release via the 
direct targeting of the gene myotrophin. 
The role of miR-375 in insulin release was 
further confirmed in vivo using the total 
mouse knockout (375KO).6 Furthermore, 
this model facilitated the identification 
of several additional targets of miR-375, 
including Elavl4/HuD, Cadm1, Gphn, and 
Rasd1. Moreover, 375KO mice exhibited 
hyperglycemia and decreased β-cell mass, 
and these effects were further exacerbated 
after crossing the knockout onto the 
leptin-deficient ob/ob background. This 
result indicated that miR-375 plays an 
essential role in the compensatory β-cell 
proliferation induced by insulin-resistance 
in ob/ob mice. Moreover, our recent obser-
vations showing loss of Ago2 also blocked 
proliferation during insulin resistance fur-
ther support a role for the miRNA path-
way in mediating cellular stress responses. 
Importantly, we showed that Ago2 is 
upregulated in the pancreatic islets of 
both genetic and diet-induced models of 
insulin resistance and obesity as a result 
of the silencing of miR-184. Furthermore, 
the inverse relationship between Ago2 and 
miR-184 was confirmed in islets of human 
subjects, further underlining the relevance 
of studying β-cell function in these mouse 
models. Of note, miR-184 was shown to 
target the gene Slc25a22, a mitochondrial 
glutamate transporter, indicating that 
miRNAs may regulate many stages of the 
canonical pathway in the β cell leading to 
insulin secretion.7
While miR-184 has been shown to 
potently regulate both growth and secre-
tion of the β cell, it remains to be deter-
mined how changes in insulin sensitivity, 
as shown in the models of obesity, may 
contribute to the direct regulation and 
function of all miRNAs in this cell 
type. Meanwhile, it is unclear whether 
miRNA function in the β cell may also 
change in response to alterations within 
its metabolic environment, such as levels 
of extracellular nutrients (glucose, amino 
acids, or fatty acids), signaling hormones, 
neurotransmitters, or perturbations in 
cell-to-cell contact with neighboring 
endocrine, endothelial, mesenchymal, or 
neuronal cells. Moreover, key transcrip-
tional regulators of miRNAs in the β 
cell as well as RNA-binding proteins that 
may specifically bind miR-184 and target 
it for degradation remain unidentified. It 
is unclear how the additional abundant 
β-cell miRNAs may coordinately target 
genes to promote insulin release as well 
as facilitate compensatory expansion of 
the β cell as metabolic demand increases. 
While miR-184 was the most significantly 
regulated miRNA in the islets of insulin-
resistant mice, additional miRNAs have 
been shown to participate in β-cell growth 
using human islet cells.8 It will presumably 
be determined that numerous miRNAs 
act in a concerted fashion to regulate mul-
tiple targets that mediate cell growth and 
the continual recruitment of insulin-con-
taining granules to the plasma membrane. 
Interestingly, it is still not known whether 
the same miRNAs perform an identical 
regulatory function in different cell types. 
As Ago2-associated sequences such as 
miR-375 are expressed in several unique 
tissues, such as the pituitary and adrenal 
gland, it is unclear how this miRNA may 
regulate growth and secretion in these 
other neuroendocrine cell types.
In summary, in light of recent find-
ings identifying components of the RNAi 
machinery in the nucleus, including 
Ago2, Dicer, and GW182, it appears only 
a matter of time before new mechanistic 
insights into the role of this pathway are 
discovered. While the identification of 
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direct targets of the miRNAs and their 
biological significance remains to be 
studied in greater detail, the role of small 
RNAs in the nucleus also remains to be 
described. The story of non-coding RNAs 
and their functional role in the pancreatic 
β cell is far from complete. In an exciting 
time of rapidly evolving technologies, the 
next 10 y are certain to bring clarity to this 
expanding narrative.
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Figure 1. regulation of β-cell growth and function by the microrNA pathway. miR-184 and miR-375 
coordinately regulate β-cell proliferation and insulin secretion. silencing of miR-184 alleviates inhi-
bition of its targets Ago2 and Slc25a22 during insulin resistance. Ago2 mediates miR-375 function on 
several target genes to regulate the release of insulin and β-cell proliferation.
